Los Angeles, CA, August 07, 2016 --(PR.com
)-- SVS Medical LLC developed the Single Vial System technology in 2010 for use with parenteral pharmaceutical products such as vaccines, antibiotics, antidotes and more. Now, SVS Medical LLC Founder Ross Tsakas has decided to publicly donate his pioneer pharmaceutical packaging delivery free of charge for companies within the DCVMN. According to public sources such as the DCVMN webpage available on the WHO website, the DCVMN network consists of 14 countries and their major vaccine manufaturing companies.
Companies in the network include:
1) Serum Institute of India
2) Fiocruz, Bio Manquinhos of Brazil
3) Biovac Institute of South Africa
In the past, undisclosed details of a potential agreement with the Serum Institute of India were made public via a Certificate of Endorsement provided by the World Health Organization promoting a mutual collaboration to launch Serum Institute vaccines within the Single Vial System. Since then, the technology has been fully developed and is market ready. According to a press release issued yesterday, Ross is also keen on donating the technology ultimately to the Gates Foundation.
Thus, a prospective partner such as the Serum Institute of India would further its global cause and receive the SVS packaging entirely free of charge while also promoting further access to its medicines. The SVS offers the potential to store and deliver twice as many vaccines at half the cost and the Poonawalla family who own the Serum Institute of India are well known for their humanitarian endeavors.
In the near future, keep your eyes here for updates on potential DCVMN collaborations to launch the SVS technology with the support of the WHO and Gates Foundation. It is sure to be a fine day for humanity.
For more information reach me Jack Burrows at @jackburrows